In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance

被引:110
作者
Annoni, Andrea [1 ]
Brown, Brian D. [1 ]
Cantore, Alessio [1 ,2 ]
Sergi, Lucia Sergi [1 ]
Naldini, Luigi [1 ,2 ]
Roncarolo, Maria-Grazia [1 ,2 ]
机构
[1] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
基金
美国国家卫生研究院;
关键词
LIVER ENDOTHELIAL-CELLS; NONOBESE DIABETIC MICE; MEDIATED GENE-TRANSFER; MYELIN BASIC-PROTEIN; IMMUNE-RESPONSE; MULTIPLE-SCLEROSIS; ENDOGENOUS MICRORNA; AUTOIMMUNE-DISEASE; LENTIVIRAL VECTORS; DENDRITIC CELLS;
D O I
10.1182/blood-2009-04-214569
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We previously showed that incorporating target sequences for the hematopoietic-specific microRNA miR-142 into an antigen-encoding transgene prevents antigen expression in antigen-presenting cells (APCs). To determine whether this approach induces immunologic tolerance, we treated mice with a miR-142-regulated lentiviral vector encoding green fluorescent protein (GFP), and subsequently vaccinated the mice against GFP. In contrast to control mice, no anti-GFP response was observed, indicating that robust tolerance to the transgene-encoded antigen was achieved. Furthermore, injection of the miR-142-regulated vector induced a population of GFP-specific regulatory T cells. Interestingly, an anti-GFP response was observed when microRNA miR-122a was inserted into the vector and antigen expression was detargeted from hepatocytes as well as APCs. This demonstrates that, in the context of lentiviral vector-mediated gene transfer, detargeting antigen expression from professional APCs, coupled with expression in hepatocytes, can induce antigen-specific immunologic tolerance. (Blood. 2009; 114: 5152-5161)
引用
收藏
页码:5152 / 5161
页数:10
相关论文
共 51 条
[1]   MECHANISMS OF CLASS-I RESTRICTED IMMUNOPATHOLOGY - A TRANSGENIC MOUSE MODEL OF FULMINANT-HEPATITIS [J].
ANDO, K ;
MORIYAMA, T ;
GUIDOTTI, LG ;
WIRTH, S ;
SCHREIBER, RD ;
SCHLICHT, HJ ;
HUANG, SN ;
CHISARI, FV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1541-1554
[2]   Strategies to Modulate Immune Responses: A New Frontier for Gene Therapy [J].
Arruda, Valder R. ;
Favaro, Patricia ;
Finn, Jonathan D. .
MOLECULAR THERAPY, 2009, 17 (09) :1492-1503
[3]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]   Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance [J].
Battaglia, M ;
Stabilini, A ;
Draghici, E ;
Gregori, S ;
Mocchetti, C ;
Bonifacio, E ;
Roncarolo, MG .
DIABETES, 2006, 55 (01) :40-49
[5]  
Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.0.CO
[6]  
2-F
[7]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[8]   Dangerous liaisons: the role of "danger" signals in the immune response to gene therapy [J].
Brown, BD ;
Lillicrap, D .
BLOOD, 2002, 100 (04) :1133-1140
[9]   A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice [J].
Brown, Brian D. ;
Cantore, Alessio ;
Annoni, Andrea ;
Sergi, Lucia Sergi ;
Lombardo, Angelo ;
Della Valle, Patrizia ;
D'Angelo, Armando ;
Naldini, Luigi .
BLOOD, 2007, 110 (13) :4144-4152
[10]   Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state [J].
Brown, Brian D. ;
Gentner, Bernhard ;
Cantore, Alessio ;
Colleoni, Silvia ;
Amendola, Mario ;
Zingale, Anna ;
Baccarini, Alessia ;
Lazzari, Giovanna ;
Galli, Cesare ;
Naldini, Luigi .
NATURE BIOTECHNOLOGY, 2007, 25 (12) :1457-1467